Literature DB >> 12135677

Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies.

Nadia Quirici1, Davide Soligo, Patrizia Bossolasco, Federica Servida, Cristina Lumini, Giorgio Lambertenghi Deliliers.   

Abstract

OBJECTIVE: Mesenchymal stem cells (MSCs) are a population of multipotent cells that can proliferate and differentiate into multiple mesodermal tissues. We previously reported that monoclonal antibodies to the low-affinity nerve growth factor receptor (alpha-LNGFR) stain bone marrow (BM) mesenchymal cells. We now show that LNGFR antibodies label primitive MSCs with high specificity and purity in adult BM, and compare these cells to those isolated by plastic adherence (PA) and CD45(-)anti-glycophorin A(-) selection.
MATERIALS AND METHODS: Low-density mononuclear cells (LD-MNCs) from normal BM were separated by PA or immunomagnetic selection for NGFR(+) or CD45(-)alpha-glycophorin A(-) cells. The three fractions were grown in Iscove's modified Dulbecco medium + 20% fetal bovine serum +/- basic fibroblast growth factor (bFGF) in order to assess their proliferative capacity and evaluate their phenotype during culture. The clonogenic potential of the MSCs was assessed using a colony-forming unit fibroblast (CFU-F) assay, whereas multipotential differentiation was determined after culture in adipocytic and osteoblastic conditioned media.
RESULTS: The NGFR(+) mesenchymal cells grown without growth factors showed persistent NGFR expression (rapidly down-regulated after the addition of bFGF) and persistent CFU-F activity. The NGFR(+) fractions were rich in clonogenic precursors: CFU-F median frequency was 1584/1 x 10(6) cells (range 325-13,793) in the NGFR(+) cells and 35/1 x 10(6) cells (range 27-112) in the LD-MNCs. The NGFR(-) fraction never showed any residual CFU-F activity. Compared with the other two fractions, the NGFR(+) cells (+/- bFGF) showed a 1 to 3 log greater expansion in the number of fibroblastic cells and a greater capacity to give rise to adipocyte colonies and induce osteoblastic differentiation, and they had similar effects in supporting the growth of hematopoietic precursors.
CONCLUSION: The data suggest that positive selection using low-affinity NGFR antibodies makes it possible to obtain homogeneous multipotent MSCs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135677     DOI: 10.1016/s0301-472x(02)00812-3

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  172 in total

1.  Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy.

Authors:  Yuko Nitahara-Kasahara; Hiromi Hayashita-Kinoh; Sachiko Ohshima-Hosoyama; Hironori Okada; Michiko Wada-Maeda; Akinori Nakamura; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

Review 2.  Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage.

Authors:  W R Otto; J Rao
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

Review 3.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

Review 4.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 5.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

6.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

Authors:  Ulrich Lindner; Jan Kramer; Jürgen Rohwedel; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

Review 7.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

8.  Reconstruction of human elastic cartilage by a CD44+ CD90+ stem cell in the ear perichondrium.

Authors:  Shinji Kobayashi; Takanori Takebe; Midori Inui; Sayaka Iwai; Hiroomi Kan; Yun-Wen Zheng; Jiro Maegawa; Hideki Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-11       Impact factor: 11.205

9.  Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury.

Authors:  Muammer Kendirci; Landon Trost; Benjamin Bakondi; Mandolin J Whitney; Wayne J G Hellstrom; Jeffrey L Spees
Journal:  J Urol       Date:  2010-08-21       Impact factor: 7.450

Review 10.  Regenerative therapy after cancer: what are the risks?

Authors:  Vera S Donnenberg; Ludovic Zimmerlin; Joseph Peter Rubin; Albert D Donnenberg
Journal:  Tissue Eng Part B Rev       Date:  2010-11-02       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.